GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma-Reference-Cited by-同舟云学术

GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma

Published:2020-04-03 Issue:3 Volume:147 Page:577-585
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Marx Sascha^ORCID,Wilken Fabian,Wagner Isabel,Marx Madlen^ORCID,Troschke-Meurer Sascha^ORCID,Zumpe Maxi^ORCID,Bien-Moeller Sandra,Weidemeier Martin,Baldauf Joerg,Fleck Steffen K.,Rauch Bernhard H.,Schroeder Henry W. S.,Lode Holger^ORCID,Siebert Nikolai^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-020-03470-3.pdf

Reference26 articles.

1. Arbit E, Cheung NK, Yeh SD, Daghighian F, Zhang JJ, Cordon-Cardo C, Pentlow K, Canete A, Finn R, Larson SM (1995) Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. Eur J Nucl Med 22:419–426. https://doi.org/10.1007/bf00839056

2. Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Investig 84:397–405. https://doi.org/10.1038/labinvest.3700070

3. Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 6:443–446. https://doi.org/10.1038/74704

4. De Felice F, Pranno N, Marampon F, Musio D, Salducci M, Polimeni A, Tombolini V (2019) Immune check-point in glioblastoma multiforme. Crit Rev Oncol Hematol 138:60–69. https://doi.org/10.1016/j.critrevonc.2019.03.019

5. Di Gaetano N, Cittera E, Nota R, Vecchi A, Grieco V, Scanziani E, Botto M, Introna M, Golay J (2003) Complement activation determines the therapeutic activity of rituximab in vivo. J Immunol 171:1581–1587. https://doi.org/10.4049/jimmunol.171.3.1581

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Functions of glycosphingolipids in the central nervous system;Glycosphingolipids in the Central Nervous System;2024

3. The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro;Cancers;2023-08-26

4. Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases;Progress in Lipid Research;2023-07

5. GD2 CAR-T cells in combination with Nivolumab exhibit enhanced antitumor efficacy;Translational Oncology;2023-06